Spoken Alpha
Bone Biologics Corp
Bone Biologics develops NB1, a bone graft device combining recombinant human protein NELL-1 with demineralized bone matrix for spinal fusion surgery. The company is in clinical-stage development, currently conducting a pilot study in Australia to evaluate safety and effectiveness in patients with degenerative disc disease undergoing lumbar spinal fusion.
Bone Biologics Corp.
Most recent reported earnings: Q1 FY2021 (Jun 29, 2021).
Behavioral analysis
Disclosures
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add BBLGW, reply to your welcome email and we'll prioritize it.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BBLGW.
$ curl https://api.spokenalpha.com/v1/companies/BBLGWFAQ
Spoken Alpha indexes BBLGW's earnings call transcripts at https://spokenalpha.com/companies/BBLGW. Each call links to attributed speakers and parsed analyst Q&A.
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2021 | 2021-06-29 | $-0.04 | $0.00 | — | $0 | — | — | EODHD |
| Q4 FY2020 | 2021-03-30 | $-0.04 | $0.00 | — | $0 | — | — | EODHD |
| Q3 FY2020 | 2020-12-30 | $-0.04 | $0.00 | — | $0 | — | — | EODHD |
| Q2 FY2020 | 2020-09-29 | $-0.03 | $0.00 | — | — | — | — | EODHD |
| Q1 FY2020 | 2020-06-29 | $-0.03 | $0.00 | — | — | — | — | EODHD |
| Q4 FY2019 | 2020-03-30 | $-0.05 | $0.00 | — | — | — | — | EODHD |
| Q3 FY2019 | 2019-12-30 | $-0.04 | $0.00 | — | — | — | — | EODHD |
| Q2 FY2019 | 2019-09-29 | $-0.05 | $0.00 | — | — | — | — | EODHD |
| Q1 FY2019 | 2019-06-29 | $-0.08 | $0.00 | — | — | — | — | EODHD |
| Q4 FY2018 | 2019-03-30 | $-0.13 | $0.00 | — | — | — | — | EODHD |
| Q3 FY2018 | 2018-12-30 | $-0.94 | $0.00 | — | — | — | — | EODHD |
| Q2 FY2018 | 2018-09-29 | $-0.08 | $0.00 | — | — | — | — | EODHD |
| Q1 FY2018 | 2018-06-29 | $-0.71 | $0.00 | — | — | — | — | EODHD |
| Q4 FY2017 | 2018-03-30 | $-0.84 | $0.00 | — | — | — | — | EODHD |
| Q3 FY2017 | 2017-12-30 | $-1.77 | $0.00 | — | — | — | — | EODHD |
| Q2 FY2017 | 2017-09-29 | $-1.53 | $0.00 | — | — | — | — | EODHD |
| Q1 FY2017 | 2017-06-29 | $0.63 | $0.00 | — | — | — | — | EODHD |
| Q4 FY2016 | 2017-03-30 | $-1.88 | $0.00 | — | — | — | — | EODHD |
| Q3 FY2016 | 2016-12-30 | $-6.26 | $0.00 | — | — | — | — | EODHD |
| Q2 FY2016 | 2016-09-29 | $-2.82 | $0.00 | — | — | — | — | EODHD |
Source: EODHD. BBLGW reported actuals as published; sparse fields render as —.